Disease management
caregiving for years, which ultimately ends with the death of a loved one. Everyone struggles to cope with multiple changes, including the burden of increasing dependence, while trying to have as many meaningful and valuable experiences as possible ( Figure 2 ).
These issues, and the tensions that arise from them, inevitably impact each person's physical well-being and their sense of safety, love, and esteem ( Figure 3 ; a modification of Maslow's Hierarchy of Human Need). 5, 6 If these issues and the resulting needs are not fully addressed and supported, they can negatively impact on patients', families', and caregivers' capacity to live meaningful and valuable lives and realize their full potential. The effects can last for the duration of a patient's life and last long after his or her death.
Palliative Care as a Response
To achieve our full potential as a society, we must strive to keep people as healthy as possible (that is, "a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity," 7, p 1 as defined by the World Health Organization). To achieve this goal, health care must address the multiple issues individuals face during a chronic illness, not just focus on curing or controlling physical manifestations of the underlying disease.
Palliative care is the newest body of knowledge and skill in health care. Recently, it has been recognized as a medical specialty in Australia, Canada, Ireland, the United Kingdom, and the United States. [8] [9] [10] It includes a wide range of therapeutic interventions that aim to prevent and relieve suffering caused by the multiple issues patients, families, and caregivers face, and the needs these create, at any stage during an acute or chronic life-threatening illness (Table 1 and Figure 1 ).
Typically, therapies to cure or control an underlying disease are the initial focus of care for patients and their health care providers. Palliative care augments these disease-modifying therapies and helps individuals achieve their full potential throughout their illness experience by helping to address the multiple issues that can lead to suffering and any related needs whenever they arise, starting from diagnosis and extending through the bereavement period ( Figure 4) . 11 Over time, as an illness advances and goals of care change, palliative care may become the total focus of care.
The concept of palliative care was first introduced in Canada in the mid-1970s. It derives from the Latin verb palliare, which means to cloak, to comfort, 1 and grew out of, and includes, hospice care-specialized care for patients and families approaching the end of a patient's life. Hospice care includes interventions to help patients and families close their lives together, manage the last hours of life, and provide bereavement care for family who survive the patient's death ( Figure 5 ).
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While some family practitioners, general internists, and specialists provide primary (basic) and secondary (advanced) palliative care, most are not yet competent with this new knowledge and skill set. Similar to other medical specialties, interdisciplinary services specializing in palliative care provide tertiary (expert) consultative services to manage challenging and complex situations, particularly when goals of care shift to focus more on comfort and quality than cure. Today, palliative care consultation is increasingly available in acute and long-term care facilities, in ambulatory outpatient settings, and in patients' homes. Specialized palliative care and hospice inpatient units and free-standing facilities have also developed to care for patients with complex situations, and when goals of care shift to focus on palliative care when the patient can no longer be cared for at home.
The Need for Psychiatry
Growing evidence indicates that psychosocial and psychiatric issues in patients with advanced life-threatening illnesses are prevalent, often unacknowledged (for example, thought of as normal responses to anticipated death), unassessed, underdiagnosed, and undertreated across all health care settings and disciplines. [14] [15] [16] With the increasing prevalence of both acute and chronic life-threatening illnesses, there are rapidly increasing opportunities and need for psychiatrists, along with other mental health professionals, to care for these patients and their families. Along with providing necessary care, these professionals will participate in education, research, and advocacy that will significantly benefit their patients, families, and health care systems worldwide.
While many palliative care experts have learned to manage numerous common psychiatric issues, most are not experts at assessing, diagnosing, or managing complex situations. A wide range of issues could benefit from psychiatric expertise (Table 1 and Figure 1 ). As patients with complex psychiatric issues in the context of advanced, life-threatening illnesses are often referred to palliative care teams, many palliative care psychiatrists are needed as consultants to, or as liaison members of, interdisciplinary palliative care teams to address this burden of suffering. These teams have many resources that increase the likelihood of psychiatrists having a significant impact, including skilled nurses, social workers, spiritual and bereavement counsellors, and volunteers.
Specific Therapeutic Expertise
As with other psychiatric illness, a combination of supportive psychotherapy and psychopharmacology is usually the best therapeutic intervention. 
Psychotherapy
Ongoing supportive psychotherapy by a skilled psychiatrist can provide a safe setting that encourages patients and families to share issues that may be causing them suffering, especially issues they may be reluctant to share with their palliative care team. Several studies have shown that group therapy reduces distress and mood symptoms in patients with advanced and (or) metastatic breast cancer. [17] [18] [19] Existential group therapy, which focuses on issues of meaning and is based on Frankl's logotherapy, 20 was also proposed as a useful intervention for dying individuals. [21] [22] [23] Chochinov et al 24 designed an individual psychotherapeutic intervention, coined Dignity Therapy, targeted at psychosocial and existential distress among patients near the end of life. They reported that most patients receiving Dignity Therapy experienced a heightened sense of dignity, purpose, and meaning, and an increased will to live. Patients receiving Dignity Therapy also reported a significantly diminished sense of suffering and reduced depressive symptoms.
Pharmacotherapy
When indicated, patients with life-threatening illnesses typically respond to the usual armamentarium of psychopharmaceuticals. Particularly important to these patients is the time required to achieve a therapeutic response.
Patients with limited life expectancy need therapies that act quickly. Many will not live even the few weeks needed to realize the effects of standard antidepressants.
Given the complexity of most psychiatric issues, along with their interplay with medical illness and therapies, most nonpsychiatrists will be at a loss, or reluctant, to use psychiatric medications properly. Almost universally, only psychiatrists have the knowledge and experience to use medications in atypical, off-label ways that may benefit these patients, such as stimulants for the rapid relief of depression, 25, 26 first-generation antipsychotics for delirium, [27] [28] [29] and benzodiazepines for irreversible delirium.
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Specific Areas of Expertise
Depression Depression is one of the most common symptoms experienced by patients with life-threatening illnesses. Prevalence of up to 42% has been reported in patients enrolled in palliative care programs. [31] [32] [33] Untreated depression can increase the perceived severity of pain and other symptoms [35] [36] [37] [38] ; affect physical health and quality of life 31, 35 ; impair a patient's capacity to make decisions, interact with caregivers, and (or) attain final goals of life; and significantly increase the probability of morbidity, mortality, 39 and suicide. [40] [41] [42] [43] [44] While there is evidence that early recognition and treatment of depression reduces disability and health care costs, further work is needed to determine whether this is true in palliative care settings. 45 Depressive symptoms are commonly underrecognized in patients with advanced life-threatening illnesses. 15 Patients, families, and clinicians sometimes assume that emotional distress is inevitable and untreatable in the context of advanced, life-threatening illnesses. 46 Patients and families often do not recognize or give adequate credence to depressive symptoms accompanied by considerable physical ailments. 47 Even when the symptoms are recognized, patients and families are often reluctant to voice emotional complaints to clinicians. The situation is further complicated by the fact that many clinicians are unable to appropriately estimate their patients' levels of psychological distress. [48] [49] [50] [51] A psychiatrist can help a palliative care team make the diagnosis. This is inherently difficult, as many of the typical symptoms of depression evolve over time and are confounded by the underlying illness and its treatment (for example, changes in weight, fatigue, sleep disturbances, decreased concentration, and altered appetite). 52 A psychiatrist can also help distinguish grieving and normal adjustment processes 53,54 from clinically significant depressive disorders. 31 Even when the symptoms are recognized, depression is frequently undertreated in patients with advanced, lifethreatening illnesses. [55] [56] [57] Older studies demonstrated that, in spite of the high prevalence rates, antidepressant medications were administered to only 3% of terminal cancer patients 46, 58 ; although, this may be improving. 33 Withholding treatment is sometimes rationalized as not interfering with normal grieving; however, this may be at the cost of ignoring a critically serious psychiatric disorder.
Both psychotherapy and standard antidepressant therapy appear effective in treating depression in patients with cancer and other significant medical problems. In a metaanalysis of patients with chronic medical illness and depression, antidepressants were shown to significantly reduce depressive symptoms. 59 Palliative care teams will benefit significantly from experienced psychiatrists who can help them decide which antidepressants to choose from amongst the armamentarium of more than 24 antidepressants with at least 7 different mechanisms of action, and when to change to an alternate antidepressant if a 4-to 6-week trial does not produce the desired results. [60] [61] [62] For depressed patients with a limited life expectancy of only weeks, who may die before the usual antidepressants are effective, psychiatrists experienced with the management of depression using off-label medications will be invaluable (for example, methylphenidate and modafinil).
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Delirium Among patients with cancer admitted to a hospital or hospice, 44% may experience delirium. It is estimated that 50% of this delirium may be reversible. 66 As patients with cancer or other diagnoses approach the end of their lives, more than 80% may experience delirium. 27, 29, [66] [67] [68] [69] [70] One-third of palliative care patients experience terminal delirium while they are actively dying. 71 Delirium can be a frightening and distressing experience for patients, families, and caregivers. 72 It is associated with significant morbidity and mortality, 27, 66, [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] and can impair the recognition and control of other physical and psychological symptoms, such as pain. 83 These symptoms can lead to unnecessary medical intervention or inpatient admissions that are frequently prolonged and costly. [79] [80] [81] [82] In patients with advanced life-threatening illnesses, delirium is often underrecognized and misdiagnosed. 81, [84] [85] [86] An experienced psychiatrist can help clinicians understand the terminology used to describe and differentiate between cognitive impairments, choose good bedside screening and diagnostic tools, and improve their understanding of delirium. 14,81 They can also help to: make an accurate diagnosis; differentiate delirium from other psychiatric disorders 67, 84 ; establish the reversibility of a delirium; and, establish the most appropriate goals of care given the patient's situation, particularly when patients are approaching the end of their lives. 30, 87 Delirium is often inappropriately treated by clinicians who are not experienced with its management. However, appropriate interventions usually improve outcomes. [27] [28] [29] [88] [89] [90] An accurate diagnosis is very important, as the treatment of agitation may vary depending on the etiology, context, and goals of care (that is, reversible, compared with irreversible, delirium, dementia, or schizophrenia). 30, 91 Psychiatrists can recommend strategies to: ensure patient, family, and caregiver safety; modify the environment and teach family and staff helpful behaviours; recommend appropriate medications, depending on whether the delirium is reversible (that is, if reversible, use antipsychotics and avoid benzodiazepines, or if irreversible terminal delirium, use benzodiazepines for their sedative, amnestic, musclerelaxant, and antiepileptic properties); and, provide ongoing support to the patient, family, caregivers, and the health care team.
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Anxiety
Although it has received little attention, anxiety is thought to occur in more than 70% of medically ill patients, especially those approaching the end of their lives. 14, 33, 94, 95 Most of these patients have worries, fears, and apprehensions that result in symptoms of anxiety but do not rise to the level of an anxiety disorder. They express fears about what their death will look like and what events will lead up to it. They frequently voice concerns about religious beliefs, spiritual issues, existential matters, or how to achieve a good death. Fear of uncontrolled symptoms or dependency are sometimes accompanied by a heightened interest in hastened death. 96 Recognizing anxiety can be particularly difficult, as dying patients often have a complex mix of physical, psychological, and psychiatric issues. 96 It frequently presents with somatic symptoms that overshadow psychological and cognitive manifestations. 97 A psychiatrist can be instrumental in helping the palliative care team use these symptoms as cues to inquire about the patient's psychological state. They can also help diagnose an underlying anxiety disorder. 98 An experienced psychiatrist will help the team with the difficult task of deciding when to intervene, and what therapies to use. 96 Nonpharmacological interventions are typically the first line of therapy in patients with advanced life-threatening illnesses. Supportive and (or) group psychotherapy, Dignity Therapy, and alternative medical approaches, such as progressive muscle relaxation, massage therapy, guided imagery, hypnosis, meditation, or aromatherapy, can be particularly useful tools to decrease anxiety. [17] [18] [19] [20] [21] [22] [23] [24] 96 If psychopharmacology is needed, a psychiatrist can suggest and monitor the effect of medications not typically used for anxiety, such as beta-blockers, mood stabilizers, and trazodone. 99 In general, benzodiazepines should not be used as first-line agents and only play a very limited role for anxiety management in this patient population. Psychiatric expertise can help minimize any inappropriate use of benzodiazepines to manage anxiety in these patients.
Care of the Family
During the Illness. Care for the family during an advanced life-threatening illness is as important as caring for the patient, particularly when the patient is a child. It involves many of the same issues that patients deal with, including the need for supportive psychotherapy, and the management of depression, anxiety, and grief. Attention to these issues can reduce burden on other family obligations (for example, work, children, social, and financial obligations), and may reduce the risk of increased morbidity and mortality among caregivers, 100-108 including the risk of major depression and complicated bereavement. [109] [110] [111] If attention is paid to the needs of the family during the patient's illness, and they are prepared for the patient's death, caregiving outcomes will improve, caregiver satisfaction will be greater, and their bereavement experience may be very different.
After a Death (Bereavement).
Psychiatrists and other mental health professionals are ideal members of bereavement teams to help identify and treat psychiatric sequelae of grief, whether the grief is normal or takes a more serious and Zisook and Shuchter 125 found that by the second month, bereavement-related depressions tended to be chronic, led to protracted biopsychosocial dysfunction, and were associated with impaired immunological function. The presence of a major depressive episode 2 months after a death is a major risk factor for depression at 1 year. 125 As such, many psychiatrists believe that all severe major depressive episodes, at any time, including all cases meeting criteria for major depression in the context of bereavement, should be diagnosed and treated similar to nonbereavement-related depressions.
Anxiety disorders also occur and can be long-lasting during bereavement. 126, 127 Jacobs et al 128 found higher than expected rates of both panic and generalized anxiety disorders throughout the first year of spousal bereavement, agoraphobia in the first 6 months, and social phobia in the next 6 months. Posttraumatic stress disorder was also reported during bereavement. 129, 130 Depression and anxiety interfere with grief work. Aggressive treatment by skilled psychiatrists and other mental health professionals will facilitate the grieving process. 118, 131 Considerable evidence now exists that an episode of major depression should be treated, even in the context of bereavement.
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Major depression is woefully underdiagnosed and rarely treated when it occurs during bereavement. 125 Five open studies 118, [130] [131] [132] [133] [134] [135] and one placebo-controlled study 13 support the safety and efficacy of antidepressants in the bereft. There was no indication that treating depression interfered with the normal grieving process; however, depression in the setting of bereavement did respond to antidepressant therapy similarly to nonbereavement-related depression. Group and individual psychotherapy, as well as psychopharmacology, were all shown to be effective for treating psychiatric syndromes in the bereaved.
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Need for Education
Inevitably, the absence of psychiatric training related to advanced life-threatening illnesses contributes to the underrecognition and undertreatment of these issues, certainly to the detriment of patients and their families. 148 Without experience, clinicians, including psychiatrists, are not adequately prepared to manage these complex patients effectively. Some may even avoid caring for these patients, as they find it very stressful. 149 To increase clinicians' knowledge and skills, formal education in the assessment, diagnosis, and management of psychiatric issues as they relate to patients and families living with life-threatening illnesses is needed, including education targeted at: · Nonpalliative care physicians and other members of the general health care team who need to achieve and maintain basic core competencies in the psychiatric aspects of palliative medicine.
· Palliative medicine experts, and other members of hospice and palliative care team, who need advanced training and expertise in the psychiatric aspects of palliative medicine.
· Psychiatrists and other mental health professionals, who can provide consultative services to hospice and palliative care teams and other health care professionals, and who need basic core competencies in the psychiatric aspects of palliative medicine; this should become a routine part of professional training programs.
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· Palliative care psychiatry specialists will require advanced training and expertise in the psychiatric aspects of palliative medicine, as well as in palliative medicine itself.
A recent survey of more than 90 psychiatry residents from 17 psychiatry residency programs in the United States demonstrated that an overwhelming majority of those surveyed believed that psychiatrists should be trained in the psychiatric aspects of end-of-life care (97%) and that there should be formal education about these issues as part of psychiatry residency training (94%). 150 With the American Board of Psychiatry and Neurology as one of the sponsors of the new subspecialty of Palliative Medicine in the United States, opportunities for psychiatrists to transition to palliative medicine fellowships need to be created and encouraged within residency training. There may even be a need for a specialized palliative medicine fellowship track targeted at psychiatrists.
The integration of psychiatrists into interdisciplinary palliative care teams will lead to the best results for patients and families. In the consultative role, psychiatrists will be in the position to educate physicians and other members of the palliative care team about the complexities of psychiatric care in this patient population and how to best use the psychiatrist's expertise.
Opportunities for Research
Given the realities that our aging population is increasing and that there is a high prevalence of psychiatric issues among patients with advanced life-threatening illnesses, there is a wonderful opportunity and a real need for psychiatric researchers to expand our knowledge and skills about defining, recognizing, assessing, and managing psychiatric issues in this patient population. To date, therapeutic interventions for psychiatric conditions have primarily been studied in the medically well. There is a paucity of solid evidence that derives from patients and families who are living with advanced illnesses, going through the dying process, and coping with bereavement.
Now that palliative medicine is a recognized medical subspecialty of the American Board of Psychiatry and Neurology, it is time for psychiatry to become more focused on expanding its role within palliative care. The opportunity to improve the quality of life for many people is greater than ever before. Innovative research will play a prominent role in improving care for these patients facing psychiatric complications, which all too often punctuate life-threatening and -limiting conditions.
Conclusion
Patients and families living with life-threatening illness often have multiple, complex, and interrelated problems that emerge as part of their underlying disease processes (Table 1 and Figure 1 ). These issues impact their sense of personhood, diminish their sense of well-being, and impair their ability to realize their full potential. Psychiatric complications in these patients are frequently challenging to assess and require expert knowledge, skills, and experience to diagnose and manage (Table 1) .
When a patient's life expectancy is believed to be short, there is frequently an urgency for the patient and family to complete numerous tasks, such as saying goodbye and realizing their full potential together before the loss occurs. After the death, bereaved families often need help to face their loss, cope with their emotions, transition their roles and responsibilities, and rebuild their lives.
While family practitioners, general internists, and palliative care clinicians can all develop core competencies regarding psychiatric complications in the context of providing palliative care, when the situation and potential treatments are complex, and the risk of medication interactions and (or) adverse events high, the health care team will benefit greatly from consultation and support from experienced psychiatrists and mental health professionals.
What better role for psychiatrists and mental health professionals to perform than to help people address their needs for physical comfort, safety, love, and esteem, and to realize their full potential? Within the context of palliative care, this means helping patients and families maintain their dignity, while achieving as much comfort and peace of mind as possible. Such an approach will enable families to cope as optimally as possible during this stressful period, and avoid the likelihood of a protracted or complicated bereavement. It will also help families to move into the next phase of their lives, it is hoped with memories of the deceased least tainted by the experience of illness and how the life of their loved one ended. In other words, it will help them "follow the path of least regret" and mitigate the possibility of a complicated and protracted bereavement (Harvey Max Chochinov, 23 May 2008, personal communication).
Not only are the personal rewards and opportunities for clinical work, education, and research in palliative care psychiatry outstanding, work in this field will help establish a standard of care that embraces the essence of quality and compassionate care. It is also worth pondering that "the standards of practice we create and the people we train will look after us when it is our turn to receive care." 12 Will your health care system be competent to maintain your comfort and meet your needs, ensuring that you and your family face death with as much comfort, peace of mind, and dignity as possible? Psychiatrists are well poised to ensure that the answer to this provocative question is yes. 
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